Depletion of SIRT6 inactivates the Keap1-NRF2 pathway and downregulates GPX4 expression, and enhances the sensitivity of gastric cancer cells to sorafenib-induced ferroptosis (Cai et al., 2021). Here, SIRT6 is linked to gastric cancer.